BuprenorphineNaltrexoneNarcotic AntagonistsDimethyl SulfoxideSubstance Withdrawal SyndromeOpioid-Related DisordersOpiate Substitution TreatmentNarcoticsNaloxoneAnalgesics, OpioidMethadoneHeroin DependenceMorphinansReceptors, Opioid, muAdministration, SublingualMorphineReceptors, OpioidMethadyl AcetateHeroinAlcoholismMorphine DependenceNalbuphineNeonatal Abstinence SyndromeDose-Response Relationship, DrugHydromorphoneEthanolBehavior, AddictiveAlcohol Withdrawal DeliriumNalorphineAlcohol Withdrawal SeizuresDimethyl SuberimidateTaurineDouble-Blind MethodReceptors, Opioid, kappaSubstance Abuse DetectionDelayed-Action PreparationsDrug InteractionsLevorphanolReceptors, Opioid, deltaOpioid PeptidesTemperancePain MeasurementAlcohol AbstinenceAnalgesicsButorphanolDiprenorphineDrug ToleranceDimethyl AdipimidateDisulfiramRats, Sprague-DawleyTime FactorsTreatment OutcomeSulfuric Acid EstersBehavior, AnimalSubstance Abuse Treatment CentersAnalgesiaDrug CombinationsOpiate AlkaloidsEuphoriaConditioning, OperantFentanylCocaine-Related DisordersEnkephalin, Ala(2)-MePhe(4)-Gly(5)-CocaineThiazinesSubstance-Related DisordersSelf AdministrationEndorphinsbeta-EndorphinPrescription Drug DiversionPrescription Drug MisuseTramadolPupilPainCentral Nervous System DepressantsMetabolic Detoxication, Drug16,16-Dimethylprostaglandin E2Drug Administration ScheduleEthylketocyclazocineDrug Therapy, CombinationTransdermal PatchDrug and Narcotic ControlStreet DrugsPain ThresholdEnkephalinsAlcohol DrinkingAdministration, CutaneousSheltered WorkshopsOxycodone